Additionally, upregulation of dual-specificity phosphatase-1 (DUSP1), a negative regulator in the MAPK signaling pathway, to healthy levels and downregulation of inflammatory MAPKs at the gene and protein levels could reduce the prevalence of childhood asthma [43]. The gene discussed is DUSP1; the disease is childhood onset asthma.